Literature DB >> 3493939

Primary sclerosing cholangitis in childhood.

M el-Shabrawi, M L Wilkinson, B Portmann, G Mieli-Vergani, S K Chong, R Williams, A P Mowat.   

Abstract

Thirteen children (8 female) with primary sclerosing cholangitis are described, in whom the diagnosis was confirmed by the presence of characteristic changes on endoscopic retrograde cholangiopancreatography. Nine had clinical features of chronic inflammatory bowel disease 1 mo to 5 yr before the onset of primary sclerosing cholangitis (6 patients) or appearing simultaneously with primary sclerosing cholangitis (3 patients). In 4 patients clinical evidence of chronic inflammatory bowel disease was absent but 1 of the 4 was found to have microscopic colitis in colonoscopic biopsy specimens. Biopsies were not performed in the remaining 3 patients. High immunoglobulin G concentrations and positive antinuclear or smooth muscle antibodies were present in all patients except 1 who had been given immunosuppressants. In 7 patients treated with immunosuppressants and followed up for 9 mo to 10 yr there was modest symptomatic improvement. This improvement was accompanied by a fall in transaminase levels in 6 of the patients and histologic improvement in 3 of 4 patients who had undergone biopsy. Greater use of endoscopic retrograde cholangiopancreatography in the last 6 yr led to the identification of 10 of these 13 cases, suggesting a higher incidence of primary sclerosing cholangitis in childhood than would appear from the literature.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3493939     DOI: 10.1016/s0016-5085(87)91082-1

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  23 in total

Review 1.  Autoimmune hepatitis.

Authors:  E A Roberts
Journal:  Indian J Pediatr       Date:  1995 Sep-Oct       Impact factor: 1.967

Review 2.  Liver disease in infancy: a 20 year perspective.

Authors:  G Mieli-Vergani; E R Howard; A P Mowat
Journal:  Gut       Date:  1991-09       Impact factor: 23.059

Review 3.  Hyaluronan in immune dysregulation and autoimmune diseases.

Authors:  Nadine Nagy; Hedwich F Kuipers; Payton L Marshall; Esther Wang; Gernot Kaber; Paul L Bollyky
Journal:  Matrix Biol       Date:  2018-04-04       Impact factor: 11.583

4.  Crohn disease with sclerosing cholangitis and liver cirrhosis in adolescence.

Authors:  G P Ramelli; O Tönz; A Zimmermann; M J Lentze
Journal:  Eur J Pediatr       Date:  1991-06       Impact factor: 3.183

Review 5.  The immunology of primary sclerosing cholangitis.

Authors:  R W Chapman
Journal:  Springer Semin Immunopathol       Date:  1990

6.  Sclerosing cholangitis: pediatric perspective.

Authors:  Nanda Kerkar; Tamir Miloh
Journal:  Curr Gastroenterol Rep       Date:  2010-06

7.  Lymphocytic colitis: clinical presentation and long term course.

Authors:  B Mullhaupt; U Güller; M Anabitarte; R Güller; M Fried
Journal:  Gut       Date:  1998-11       Impact factor: 23.059

Review 8.  Primary sclerosing cholangitis, autoimmune hepatitis and overlap syndromes in inflammatory bowel disease.

Authors:  Rebecca Saich; Roger Chapman
Journal:  World J Gastroenterol       Date:  2008-01-21       Impact factor: 5.742

9.  Elevation of activated gamma delta T cell receptor bearing T lymphocytes in patients with autoimmune chronic liver disease.

Authors:  L Wen; M Peakman; G Mieli-Vergani; D Vergani
Journal:  Clin Exp Immunol       Date:  1992-07       Impact factor: 4.330

10.  Antineutrophil antibody: a test for autoimmune primary sclerosing cholangitis in childhood?

Authors:  S K Lo; R W Chapman; P Cheeseman; C P Charlton; J A Walker-Smith; G Mieli-Vergani; K A Fleming
Journal:  Gut       Date:  1993-02       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.